Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs

Por um escritor misterioso

Last updated 22 janeiro 2025

Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs

Frontiers Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy

Frontiers in Pharmacology

Genes, Free Full-Text

Pediatric acute lymphoblastic leukemia

Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia - ScienceDirect

Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment - ScienceDirect

pediatric acute lymphoblastic leukemia - List of Frontiers' open access articles

Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics

Frontiers Prophylactic alpha blockers fail to prevent postoperative urinary retention following orthopaedic procedures: evidence from a meta-analysis and trial sequential analysis of comparative studies

Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients

Recomendado para você